Evaluation Of The Protective Role Of Empagliflozin In Inflammation-Triggered Kidney Disease In Preclinical Settings. Int. J. Environ. Sci. [Internet]. 2025 Sep. 1 [cited 2026 Sep. 22];:3552-8. Available from: https://theaspd.com/index.php/ijes/article/view/9070